Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: Plasmatic protein binding and cell uptake

Biochemical Pharmacology

Volumn 68, Issue 6, 2004, Pages 1113-1118

  Jannin, Brigitte ^a   Menzel, Matthias ^a   Berlot, Jean Pierre ^a   Delmas, Dominique ^a   Lançon, Allan ^a   Latruffe, Norbert ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Albumin; bovine serum albumin; BSA; Cell uptake; Exclusion chromatography; Fluorescence; Protein binding; Resveratrol

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; FATTY ACID; LIPOPROTEIN; PLASMA PROTEIN; RECEPTOR; RESVERATROL;

BEVERAGE; BINDING AFFINITY; CELL ACTIVITY; CELL MEMBRANE; CELL SURFACE; CHEMOPROPHYLAXIS; CIRCULATION; CONFERENCE PAPER; DIFFUSION; DRINKING; DRUG BINDING; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG TARGETING; DRUG TRANSPORT; EPIDEMIOLOGICAL DATA; FOOD INTAKE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SPACE; LIVER CELL; MOLECULAR INTERACTION; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TISSUE DISTRIBUTION;

ANIMALS; ANTICARCINOGENIC AGENTS; BIOLOGICAL TRANSPORT; BLOOD PROTEINS; FATTY ACIDS; HUMANS; PROTEIN BINDING; SERUM ALBUMIN; STILBENES; TUMOR CELLS, CULTURED;

EID: 4143141119     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.04.028     Document Type: Conference Paper

References (32)

1. Tomera J.F. Current knowledge of the health benefits and disadvantages of wine consumption. Trends Sci. Tech. 10:1999;129-138
2. Surh Y.J. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 428:1999;305-327
3. Frémont L. Biological effects of resveratrol. Life Sci. 66:2000;663-673
4. Latruffe N., Delmas D., Jannin B., Cherkaoui-Malki M., Passilly-Degrace P., Berlot J.P. Molecular analysis on the chemopreventive properties of resveratrol a plant polyphenol microcomponent. Int. J. Mol. Med. 10:2002;755-760
5. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 425:2003;191-196
6. Renaud S.C., Guéguen R., Schenker J., d'Houtaud A. Alcohol and mortality in middle-aged men from eastern France. Epidemiology. 9:1998;184-188
7. Delmas D., Jannin B., Cherkaoui Malki M., Latruffe N. Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines. Oncol. Rep. 7:2000;847-852
8. Delmas D., Passilly-Degrace P., Jannin B., Cherkaoui-Malki M., Latruffe N. Resveratrol a chemopreventive agent disrupts the cell cycle control of human SW480 colorectal tumor cells. Int. J. Mol. Med. 10:2002;193-199
9. Delmas D., Rebe C., Lacour S., Filomenko R., Athias A., Gambert P., et al. Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death inducing signaling complex in colon cancer cells. J. Biol. Chem. 278:2003;41482-41490
10. Belguendouz L., Fremont L., Linard A. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem. Pharmacol. 53:1997;1347-1355
11. Khan M.A., Muzammil S., Musarrat J. Differential binding of tetracyclines with serum albumin and induced structural alterations in drug-bound protein. Int. J. Biol. Macromol. 30:2002;243-249
12. Lançon A., Delmas D., Osman H., Thénot J.P., Jannin B., Latruffe N. Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochem. Biophys. Res. Commun. 316:2004;1132-1137
13. Kaldas M.I., Walle U.K., Walle T. Resveratrol transport and metabolism by human intestinal Caco-2 cells. J. Pharm. Pharmacol. 55:2002;307-312
14. Goldberg D.M., Yan J., Soleas G.J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 36:2003;79-87
15. Bertelli A., Bertelli A.A.E., Gozzini A., Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp. Clin. Res. 24:1998;133-138
16. 14C ]-trans-resveratrol a cancer chemopreventive polyphenol in mouse tissues after oral administration Life Sci. 72:2003;2219-2233
17. Manach C., Morand C., Texier O., Favier M.L., Agullo G., Demigné C., et al. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J. Nutr. 125:1995;1911-1922
18. Sengupta B., Sengupta P.K. The interaction of quercetin with human serum albumin: a fluorescence spectroscopic study. Biochem. Biophys. Res. Commun. 299:2002;400-403
19. Belguendouz L., Frémont L., Gozzelino M.-T. Interaction of trans-resveratrol with plasma proteins. Biochem. Pharmacol. 55:1998;811-816
20. Guharay J., Sengupta B., Sengupta P.K. Protein-flavonol interaction: fluorescence spectroscopic study. Proteins. 43:2001;75-81
21. Curry S., Brick P., Franks N.P. Fatty acid binding to human serum albumin: new insights from crystallographic studies. Biochim. Biophys. Acta. 1441:1999;131-140
22. Bhattacharya A.A., Grüne T., Curry S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J. Mol. Biol. 303:2000;721-732
23. Ivanov V., Carr A.C., Frei B. Red wine antioxidants bind to human lipoproteins and protect them from metal ion-dependent and -independent oxidation. J. Agric. Food Chem. 49:2001;4442-4449
24. Blache D., Rustan I., Durand P., Lesgards G., Loreau N. Gas chromatographic analysis of resveratrol in plasma, lipoproteins and cells after in vitro incubations. J. Chromatogr. B. 702:1997;103-110
25. Lamuela-Raventos R.M., Covas M.I., Fito M., Marrugat J., de la Torre-Boronat M.C. Detection of dietary antioxidant phenolic compounds in human LDL. Clin. Chem. 45:1999;1870-1872
26. Brunet M.J., Blade C., Salvado M.J., Arola L. Human apo A-1 and rat transferrin are the principal plasma proteins that bind catechins. J. Agric. Food Chem. 50:2002;2708-2712
27. Kaamanen M., Adlercreutz H., Jauhiainen M., Tikkanen M.J. Accumulation of genistein and lipophilic genistein derivatives in lipoproteins during incubation with human plasma in vitro. Biochim. Biophys. Acta. 1631:2003;147-152
28. Glatz J.F.C., van der Vusse G.J. Cellular fatty-acid binding proteins: their function and physiological significance. Prog. Lipid Res. 35:1996;243-282
29. Casper R.F., Quesne M., Rogers I.M., Shirota T., Jolivet A., Milgrom E., et al. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol. Pharmacol. l56:1999;784-790
30. Bowers J.L., Tyulmnkov V.V., Jernigan S.C., Klinge C.M. Resveratrol acts a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology. 141:2000;3657-3667
31. Abou-Zeil L.A., El-Mowafy A.M. Differential recognition of resveratrol isomers by the human œstrogen receptor-alpha: molecular dynamics evidence for stereoselective ligand binding. Chirality. 16:2004;190-195
32. Marier J.F., Vachon P., Gritsas A., Zhang J., Moreau J.P., Ducharme M.P. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J. Pharmacol. Exp. Ther. 302:2002;369-373